— Know what they know.
Not Investment Advice
Also trades as: 600016.SS (SHH) · $vol 131M · 1988.HK (HKSE) · $vol 11M · CGMBF (OTC) · $vol 0M

CMAKY OTC

China Minsheng Banking Corp., Ltd.
1W: -6.9% 1M: +7.2% 3M: +7.2% YTD: -3.8% 1Y: -11.4% 3Y: +56.3% 5Y: +58.0%
$4.33
+0.00 (+0.00%)
 
OTC · Financial Services · Banks - Regional · Tech Score Sell · Power 51 · $19.0B mcap · 2.66B float · 0.0001% daily turnover · Short 43% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
1
ROE
3
ROA
4
D/E
1
P/E
4
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CMAKY receives an overall rating of B+. Strongest factors: ROA (4/5), P/E (4/5), P/B (5/5). Areas of concern: DCF (1/5), D/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B B+
2026-09-09 C+ B
2026-09-08 B C+
2026-08-28 B- B
2026-08-14 B B-
2026-06-30 None ADDED
2026-06-28 EXISTED None
2026-06-15 None ADDED
2026-06-13 EXISTED None
2026-06-01 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
39
Balance Sheet
41
Earnings Quality
61
Growth
27
Value
—
Momentum
0
Safety
—
Cash Flow
18

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman-B Score
1.94
Grey Zone
Piotroski F-Score
4/9
✓ ✗ ✗ ✗ ✓ ✓ ✗ ✓ ✗
Beneish M-Score
-3.51
Unlikely Manipulator
Ohlson O-Score
-6.60
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB
Score: 41.1/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: -4.01x
Accruals: 1.9%
The Altman-B Score replaces the traditional Z-Score for banks and financial institutions. It weights equity-to-assets, return on assets, retained earnings, market value coverage, and cash reserves — metrics that better capture bank solvency than manufacturing-oriented ratios. CMAKY scores 1.94, placing it in the Grey Zone (safe > 3.0, distress < 1.5). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CMAKY scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CMAKY's score of -3.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CMAKY's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CMAKY receives an estimated rating of BB (score: 41.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CMAKY's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
5.43x
PEG
-0.64x
P/S
0.60x
P/B
0.26x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$156.26
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 5.4x earnings, CMAKY trades at a deep value multiple. Graham's intrinsic value formula yields $156.26 per share, suggesting a potential 3509% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.954
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
0.123
EBIT / Rev
×
Asset Turnover
0.033
Rev / Assets
×
Equity Multiplier
11.480
Assets / Equity
=
ROE
4.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CMAKY's ROE of 4.5% is driven by financial leverage (equity multiplier: 11.48x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.95 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$57.96
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CMAKY's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CMAKY trades at a premium to its adjusted intrinsic value of $57.96, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 5.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.33
Median 1Y
$3.97
5th Pctile
$1.83
95th Pctile
$8.72
Ann. Volatility
45.0%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
ROE 5.9% 5.8% 6.2% 5.9% 5.6% 5.5% 6.0% 6.0% 5.7% 5.8% 6.2% 5.6% 5.9% 5.2% 5.4% 4.9% 5.0% 3.8% 5.2% 4.5% 4.45%
ROA 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.4% 0.4% 0.4% 0.4% 0.3% 0.4% 0.4% 0.39%
ROIC 5.3% 6.0% 4.7% 4.7% 4.2% 3.7% 5.0% 6.1% 5.2% 4.8% 1.2% 4.2% 1.3% 3.4% 3.1% 2.9% 2.7% 3.4% 5.2% 4.7% 4.66%
ROCE 1.7% 1.7% 1.1% 1.8% 1.7% 1.7% 1.0% 2.1% 1.9% 1.8% 0.6% 1.7% 1.0% 1.4% 1.4% 1.3% 1.3% 1.1% 1.6% 1.4% 1.41%
Gross Margin 54.0% 52.8% 49.7% 49.2% 49.0% 46.5% 46.5% 47.8% 45.5% 45.6% 45.4% 45.7% 45.9% 48.2% 49.1% 52.5% 53.1% 54.7% 58.6% 59.7% 59.70%
Operating Margin 14.6% 11.2% -3.2% 20.9% 14.3% 12.7% 1.7% 20.9% 11.4% 14.3% 2.3% 20.3% 11.5% 12.0% 2.9% 20.3% 12.8% 4.0% 20.1% 12.2% 12.24%
Net Margin 14.3% 11.0% -1.4% 18.4% 14.2% 12.4% 2.0% 18.5% 12.5% 12.9% 3.0% 17.9% 12.6% 11.2% 2.6% 18.2% 12.9% 3.2% 17.8% 12.8% 12.83%
EBITDA Margin 14.6% 11.2% -3.2% 20.9% 14.3% 12.7% 1.7% 20.9% 11.4% 14.3% 2.3% 20.3% 11.5% 12.0% 2.9% 20.3% 12.8% 4.0% 20.1% 12.2% 12.24%
FCF Margin 26.4% 92.6% 45.5% 72.1% -21.0% -54.3% 52.2% 79.3% 62.3% 97.8% 21.3% -96.7% -1.1% -85.9% -83.6% -79.0% -62.2% -1.7% -1.6% -51.8% -51.77%
OCF Margin 28.4% 95.9% 48.5% 75.0% -16.4% -51.1% 55.8% 83.2% 64.3% 1.0% 24.1% -92.1% -1.1% -83.1% -80.2% -78.1% -59.7% -1.7% -1.6% -47.1% -47.07%
ROE 3Y Avg snapshot only 4.87%
ROE 5Y Avg snapshot only 5.22%
ROA 3Y Avg snapshot only 0.42%
ROIC 3Y Avg snapshot only 4.46%
ROIC Economic snapshot only 1.89%
Cash ROA snapshot only -1.55%
Cash ROIC snapshot only -18.79%
CROIC snapshot only -20.66%
NOPAT Margin snapshot only 11.67%
Pretax Margin snapshot only 12.32%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 18.54%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 5.432
P/S Ratio — — — — — — — — — — — — — — — — — — — — 0.597
P/B Ratio — — — — — — — — — — — — — — — — — — — — 0.256
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $156.26
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.17 0.16 0.20 0.14 0.15 0.13 0.20 0.14 0.14 0.13 0.15 0.13 0.19 0.14 0.14 0.13 0.15 0.20 0.18 0.17 0.170
Quick Ratio 0.17 0.16 0.40 0.14 0.15 0.13 0.41 0.14 0.14 0.13 0.70 0.13 0.36 0.14 0.14 0.13 0.15 0.20 0.18 0.17 0.170
Debt/Equity 1.38 1.14 1.37 1.28 1.45 1.45 1.26 1.09 1.21 1.20 4.78 1.27 4.75 1.51 1.61 1.61 1.65 1.62 1.40 1.26 1.256
Net Debt/Equity 0.09 -0.07 0.28 0.24 0.32 0.50 0.20 -0.03 0.09 0.19 4.35 0.31 3.75 0.53 0.64 0.71 0.68 0.09 -0.03 -0.09 -0.086
Debt/Assets 0.11 0.10 0.11 0.11 0.12 0.12 0.10 0.09 0.10 0.10 0.34 0.11 0.35 0.12 0.13 0.13 0.15 0.14 0.13 0.11 0.114
Debt/EBITDA 24.38 20.96 22.06 21.96 25.73 25.85 20.28 17.73 21.02 20.15 70.31 22.19 73.84 28.31 30.31 31.70 33.92 40.90 25.70 27.95 27.946
Net Debt/EBITDA 1.52 -1.23 4.48 4.12 5.65 8.85 3.20 -0.52 1.63 3.24 63.96 5.45 58.24 9.85 12.09 13.94 14.03 2.36 -0.63 -1.92 -1.925
Interest Coverage 0.22 0.21 0.23 0.22 0.22 0.22 0.24 0.24 0.22 0.23 0.23 0.22 0.22 0.21 0.22 0.23 0.24 0.21 0.32 0.28 0.283
Equity Multiplier 12.29 11.96 12.11 12.21 12.40 11.92 12.09 12.36 12.46 12.11 13.96 12.09 13.46 12.16 12.16 11.93 11.28 11.36 11.20 11.06 11.059
Cash Ratio snapshot only 0.170
Debt Service Coverage snapshot only 0.283
Cash to Debt snapshot only 1.069
FCF to Debt snapshot only -0.150
Defensive Interval snapshot only 3043.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.033
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 2.52 2.55 2.56 2.61 2.54 2.53 2.54 2.68 2.64 2.67 2.65 2.59 2.50 2.53 2.49 2.43 2.45 4.65 4.71 4.66 4.663
Payables Turnover — — — — — — — — — — — — — — — — — — — — —
DSO 145 143 143 140 144 144 143 136 138 136 138 141 146 144 147 150 149 78 78 78 78.3 days
DIO 0 0 -895 0 0 0 -1780 0 0 0 -1787 0 -771 0 -1007 0 -909 0 0 0 0.0 days
DPO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 —
Cash Conversion Cycle 145 143 -752 140 144 144 -1637 136 138 136 -1649 141 -626 144 -860 150 -760 78 78 78 —
Fixed Asset Turnover snapshot only 4.161
Cash Velocity snapshot only 0.272
Capital Intensity snapshot only 30.335
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Revenue -6.3% -6.1% -4.6% -3.6% -4.2% -6.3% -7.1% -4.7% -2.9% 0.2% 2.5% 1.1% -0.5% -2.7% -5.5% -6.5% -6.5% -8.0% -8.4% -9.5% -9.47%
Net Income -36.0% -28.8% 0.2% 2.9% 0.2% 0.6% 2.6% 7.3% 6.0% 7.3% 1.6% -2.1% 0.3% -6.7% -9.8% -9.8% -9.6% -23.0% 8.1% -4.5% -4.46%
EPS -35.4% -19.1% 12.2% 0.9% -5.4% -4.9% 3.2% 8.4% 11.1% 12.5% 1.6% -1.1% 0.3% -6.7% -14.0% -11.0% -9.9% -30.5% 12.1% -5.2% -5.21%
FCF 2.9% 5.4% 2.6% 2.4% -1.8% -1.5% 6.6% 4.8% 3.9% 2.8% -58.2% -2.2% -2.8% -1.9% -4.7% 23.6% 47.1% -86.2% -79.4% 40.7% 40.70%
EBITDA -45.2% -39.0% -3.0% 2.0% 1.9% 4.9% 4.4% 10.0% 6.7% 10.0% 0.5% -2.9% 1.9% -8.3% -8.8% -9.6% -7.4% -19.1% 12.2% -4.3% -4.27%
Op. Income -45.2% -39.0% -3.0% 2.0% 1.9% 4.9% 4.4% 10.0% 6.7% 10.0% 0.5% -2.9% 1.9% -8.3% -8.8% -9.6% -7.4% -19.1% 12.2% -4.3% -4.27%
OCF Growth snapshot only 45.45%
Asset Growth snapshot only 0.14%
Equity Growth snapshot only 8.06%
Debt Growth snapshot only -15.60%
Shares Change snapshot only 0.79%
Dividend Growth snapshot only -45.89%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.2% 1.1% 0.6% -0.7% -1.7% -2.7% -3.7% -4.0% -4.5% -4.1% -3.2% -2.4% -2.5% -3.0% -3.4% -3.4% -3.3% -3.6% -3.9% -5.1% -5.07%
Revenue 5Y 4.5% 4.5% 3.9% 3.1% 2.1% 1.3% 0.6% 0.5% -0.1% -0.6% -0.6% -1.2% -1.7% -2.1% -2.8% -3.5% -4.1% -4.6% -4.7% -4.7% -4.70%
EPS 3Y -14.0% -13.6% -11.2% -13.6% -16.0% -16.5% -13.4% -13.2% -12.1% -4.7% 5.6% 2.7% 1.8% -0.0% -3.4% -1.5% 0.1% -10.0% -0.7% -5.9% -5.85%
EPS 5Y -7.0% -6.5% -6.1% -7.4% -8.7% -8.8% -6.5% -6.6% -7.7% -7.1% -6.0% -7.1% -7.9% -9.4% -10.7% -10.4% -9.3% -10.9% 2.5% -1.8% -1.81%
Net Income 3Y -14.2% -14.7% -11.9% -13.3% -14.7% -15.0% -13.1% -13.2% -12.1% -8.4% 1.4% 2.6% 2.1% 0.3% -2.1% -1.8% -1.3% -8.3% -0.3% -5.5% -5.50%
Net Income 5Y -7.0% -7.1% -6.4% -7.1% -7.8% -7.8% -6.7% -6.7% -7.7% -7.7% -6.6% -7.3% -8.0% -9.2% -9.7% -10.4% -9.2% -11.2% 0.4% -1.4% -1.40%
EBITDA 3Y -19.3% -20.2% -15.4% -17.0% -18.5% -18.7% -16.9% -16.9% -15.8% -11.0% 0.6% 2.9% 3.5% 1.9% -1.4% -1.1% 0.2% -6.6% 1.0% -5.6% -5.63%
EBITDA 5Y -11.6% -11.8% -10.0% -10.6% -11.0% -10.8% -9.3% -9.2% -10.6% -10.1% -8.7% -9.4% -10.1% -11.6% -12.0% -12.8% -10.9% -12.2% 0.8% -1.2% -1.16%
Gross Profit 3Y 5.4% 3.8% 2.5% -0.3% -2.9% -5.6% -7.6% -8.5% -9.8% -9.7% -8.7% -8.2% -7.9% -7.5% -6.9% -5.1% -3.0% -1.2% 0.5% 0.6% 0.58%
Gross Profit 5Y 2.3% 2.2% 1.7% 1.4% 1.0% 0.3% -0.3% -0.3% -1.3% -1.9% -2.1% -3.3% -4.3% -4.8% -5.5% -5.7% -5.7% -5.8% -4.8% -4.1% -4.08%
Op. Income 3Y -19.3% -20.2% -15.4% -17.0% -18.5% -18.7% -16.9% -16.9% -15.8% -11.0% 0.6% 2.9% 3.5% 1.9% -1.4% -1.1% 0.2% -6.6% 1.0% -5.6% -5.63%
Op. Income 5Y -11.6% -11.8% -10.0% -10.6% -11.0% -10.8% -9.3% -9.2% -10.6% -10.1% -8.7% -9.4% -10.1% -11.6% -12.0% -12.8% -10.9% -12.2% 0.8% -1.2% -1.16%
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y -37.2% -20.7% -32.2% -22.2% — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y -36.3% -20.3% -31.5% -21.8% — — — — — — — — — — — — — — — — —
Assets 3Y 5.3% 5.6% 5.1% 4.9% 4.9% 4.4% 2.8% 3.0% 2.3% 2.8% 3.4% 3.0% 2.2% 3.1% 4.0% 2.8% 2.0% 3.2% 2.6% 0.8% 0.83%
Assets 5Y 6.1% 4.5% 3.4% 3.7% 4.9% 4.5% 4.2% 4.8% 4.7% 4.7% 5.1% 4.5% 3.6% 4.2% 3.2% 2.3% 1.7% 2.5% 2.5% 2.0% 1.99%
Equity 3Y 13.2% 12.6% 11.0% 10.3% 7.3% 6.8% 5.0% 4.6% 5.2% 5.2% 1.2% 5.4% -0.8% 2.6% 3.8% 3.6% 5.3% 4.8% 5.3% 4.6% 4.63%
Book Value 3Y 13.5% 14.0% 11.8% 10.0% 5.7% 4.9% 4.7% 4.6% 5.2% 9.5% 5.3% 5.5% -1.1% 2.3% 2.4% 3.9% 6.8% 2.9% 4.9% 4.2% 4.23%
Dividend 3Y 7.8% -9.0% -5.3% -5.7% -13.3% 1.2% -1.5% -1.1% -3.3% 3.6% 14.9% 10.0% 0.9% 4.8% -2.9% -2.7% 4.6% -7.6% -32.6% -18.6% -18.61%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.78 0.73 0.67 0.46 0.26 0.13 0.04 0.01 0.03 0.18 0.27 0.66 0.89 0.89 0.88 0.94 0.94 0.92 0.90 0.90 0.897
Earnings Stability 0.21 0.33 0.48 0.48 0.61 0.71 0.66 0.62 0.74 0.79 0.59 0.55 0.62 0.67 0.46 0.41 0.42 0.64 0.01 0.19 0.188
Margin Stability 0.93 0.93 0.94 0.96 0.96 0.95 0.94 0.94 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.92 0.92 0.91 0.91 0.907
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.86 0.88 1.00 0.99 1.00 1.00 0.99 0.97 0.98 0.97 0.99 0.99 1.00 0.97 0.96 0.96 0.96 0.91 0.97 0.98 0.982
Earnings Smoothness 0.56 0.66 1.00 0.97 1.00 0.99 0.97 0.93 0.94 0.93 0.98 0.98 1.00 0.93 0.90 0.90 0.90 0.74 0.92 0.95 0.954
ROE Trend -0.05 -0.04 -0.02 -0.02 -0.02 -0.02 -0.00 -0.00 0.00 0.00 0.01 -0.00 0.01 -0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.009
Gross Margin Trend 0.00 -0.01 -0.02 -0.03 -0.04 -0.06 -0.06 -0.06 -0.06 -0.05 -0.04 -0.04 -0.03 -0.01 0.00 0.02 0.05 0.06 0.08 0.09 0.092
FCF Margin Trend 0.60 1.31 0.73 1.03 -0.28 -0.91 0.43 0.68 0.60 0.79 -0.28 -1.72 -1.31 -1.08 -1.20 -0.70 -0.38 -1.80 -1.33 0.36 0.361
Sustainable Growth Rate -1.0% 1.7% 1.7% 1.5% 1.1% 1.3% 1.9% 2.0% 1.9% 1.7% 0.6% 0.5% 1.8% 0.6% 0.3% 0.4% 0.8% 0.2% 3.8% 2.1% 2.13%
Internal Growth Rate — 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.1% 0.0% 0.3% 0.2% 0.19%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.83 9.51 4.52 7.09 -1.56 -4.72 4.71 6.99 5.61 8.63 2.06 -7.99 -9.24 -7.47 -7.17 -7.02 -5.35 -18.23 -12.11 -4.01 -4.006
FCF/OCF 0.93 0.97 0.94 0.96 1.28 1.06 0.94 0.95 0.97 0.98 0.88 1.05 1.03 1.03 1.04 1.01 1.04 1.02 1.02 1.10 1.100
FCF/Net Income snapshot only -4.405
OCF/EBITDA snapshot only -3.820
CapEx/Revenue 2.0% 3.3% 3.0% 2.9% 4.6% 3.2% 3.6% 4.0% 2.0% 2.3% 2.8% 4.5% 3.2% 2.8% 3.4% 0.9% 2.5% 4.1% 3.8% 4.7% 4.70%
Accruals Ratio -0.01 -0.04 -0.02 -0.03 0.01 0.03 -0.02 -0.03 -0.02 -0.04 -0.01 0.04 0.05 0.04 0.03 0.03 0.03 0.06 0.06 0.02 0.019
Sloan Accruals snapshot only 0.000
Cash Flow Adequacy snapshot only -4.346
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 7.24%
Dividend/Share $8.73 $5.28 $5.63 $5.57 $5.62 $5.47 $5.45 $5.44 $5.31 $5.66 $7.35 $7.30 $5.52 $6.58 $6.69 $6.58 $6.02 $4.94 $2.15 $3.56 $2.54
Payout Ratio 1.2% 70.5% 72.1% 73.9% 79.4% 76.8% 67.7% 66.6% 67.6% 70.7% 89.8% 90.3% 70.0% 88.0% 95.0% 91.4% 84.8% 95.1% 27.3% 52.2% 52.20%
FCF Payout Ratio 44.4% 7.7% 17.0% 10.9% — — 15.3% 10.0% 12.4% 8.4% 49.5% — — — — — — — — — —
Total Payout Ratio 1.2% 70.5% 72.1% 73.9% 79.4% 76.8% 67.7% 66.6% 67.6% 70.7% 89.8% 90.3% 70.0% 88.0% 95.0% 91.4% 84.8% 95.1% 27.3% 52.2% 52.20%
Div. Increase Streak 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.02 0.97 0.97 0.98 0.98 0.95 0.95 0.97 0.95 0.96 0.96 0.96 0.97 0.95 0.96 0.93 0.92 0.91 0.95 0.954
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
EBIT Margin 0.10 0.10 0.11 0.11 0.11 0.11 0.12 0.13 0.12 0.12 0.12 0.12 0.12 0.11 0.12 0.12 0.12 0.10 0.14 0.12 0.123
Asset Turnover 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.033
Equity Multiplier 12.89 12.46 12.60 12.57 12.35 11.94 12.10 12.28 12.43 12.02 12.99 12.22 12.93 12.14 12.99 12.01 12.26 11.74 11.66 11.48 11.480
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $7.47 $7.49 $7.81 $7.53 $7.07 $7.12 $8.06 $8.17 $7.86 $8.01 $8.18 $8.08 $7.88 $7.48 $7.04 $7.19 $7.10 $5.20 $7.88 $6.82 $6.82
Book Value/Share $132.67 $135.21 $130.44 $132.46 $128.58 $130.40 $137.02 $140.54 $140.11 $141.85 $125.53 $147.53 $128.17 $144.55 $140.06 $148.44 $156.71 $142.16 $158.18 $159.15 $139.91
Tangible Book/Share $131.53 $134.04 $129.96 $131.27 $127.43 $129.25 $136.45 $139.25 $138.80 $140.55 $124.15 $146.13 $126.70 $143.07 $138.31 $146.64 $154.91 $140.34 $156.28 $157.33 $157.33
Revenue/Share $74.34 $74.26 $72.84 $71.19 $67.33 $65.76 $68.05 $68.60 $68.55 $69.06 $69.78 $70.08 $68.23 $67.19 $62.89 $64.60 $63.58 $55.76 $59.73 $58.02 $58.80
FCF/Share $19.65 $68.76 $33.15 $51.33 $-14.12 $-35.72 $35.53 $54.38 $42.74 $67.52 $14.85 $-67.74 $-75.02 $-57.73 $-52.58 $-51.05 $-39.56 $-97.03 $-97.77 $-30.04 $-58.14
OCF/Share $21.12 $71.21 $35.30 $53.40 $-11.04 $-33.60 $37.98 $57.11 $44.08 $69.13 $16.83 $-64.55 $-72.81 $-55.84 $-50.47 $-50.46 $-37.97 $-94.74 $-95.50 $-27.31 $-55.10
Cash/Share $171.64 $163.47 $142.14 $138.00 $145.13 $124.09 $145.00 $157.11 $156.69 $142.35 $54.21 $141.30 $128.63 $142.43 $135.24 $133.67 $151.24 $217.04 $227.51 $213.59 $59.84
EBITDA/Share $7.51 $7.37 $8.09 $7.74 $7.23 $7.30 $8.49 $8.61 $8.08 $8.42 $8.53 $8.44 $8.24 $7.72 $7.43 $7.53 $7.60 $5.63 $8.64 $7.15 $7.15
Debt/Share $183.04 $154.42 $178.36 $169.84 $185.99 $188.70 $172.16 $152.62 $169.91 $169.60 $599.96 $187.34 $608.63 $218.47 $225.05 $238.61 $257.87 $230.31 $222.04 $199.82 $199.82
Net Debt/Share $11.40 $-9.06 $36.22 $31.83 $40.86 $64.61 $27.16 $-4.49 $13.21 $27.26 $545.75 $46.04 $480.00 $76.04 $89.80 $104.95 $106.63 $13.27 $-5.46 $-13.76 $-13.76
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Altman-B Score — — — — — — — — — — — — — — — — — — — — 1.941
Piotroski F-Score 5 5 7 5 1 1 7 6 6 7 3 3 5 4 3 2 3 3 6 4 4
Beneish M-Score -1.96 -2.64 -2.29 -2.68 -2.22 -2.58 -2.59 -2.60 -2.52 -2.58 -2.35 -2.15 -1.82 -2.27 -1.74 -2.50 -2.73 -3.30 -3.04 -3.51 -3.515
Ohlson O-Score snapshot only -6.603
Net-Net WC snapshot only $-1384.48
EVA snapshot only $-34395100000.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 41.30 54.80 47.90 53.00 37.40 37.40 48.80 54.20 44.60 54.80 33.90 37.40 31.20 37.40 37.40 35.15 35.15 41.15 43.40 41.15 41.150
Credit Grade snapshot only 12
Credit Trend snapshot only 6.000
Implied Spread (bps) snapshot only 475.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms